MKL Stock Analysis: Markel | NYSE
Insurance - Property & Casualty | NYSE, USA | Market Cap: 24.753m USD | 12M Return: -2.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 153M
EPS Trend: 83.2%
Qual. Beats: 0
Rev. Trend: 43.4%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Markel Group Inc. (NYSE: MKL) is a diversified holding company headquartered in Glen Allen, Virginia. Founded in 1930 and publicly listed since 1986, the company was renamed from Markel Corporation to Markel Group Inc. in May 2023 to better reflect its expanded business mix beyond pure insurance.
The companys core operations are in property and casualty insurance, conducted through the Markel Insurance segment across the United States, the United Kingdom, Bermuda, and other international markets. It underwrites specialty lines including general and professional liability, workers compensation, marine and energy, personal lines, and credit and surety products, with a focus on niche and hard-to-place risks rather than high-volume standard coverage.
Markel also owns and operates a wide range of non-insurance businesses through its Industrial and Consumer and Other segments, including exterior building products, homebuilding, manufactured housing communities, leather handbags and accessories, and specialty industrial equipment such as dredges, cranes, and precast concrete. Its Financial segment invests in asset and wealth management firms and offers insurance-linked securities and insurance management services, reflecting a holding-company model that combines specialty insurance underwriting with diversified operating businesses.
- Specialty insurance premium growth and combined ratio drive underwriting profit
- Markel Industrial operating companies deliver diversified revenue across homebuilding and manufacturing
- Catastrophe losses and severe weather pressure property insurance segment margins
| Net Income: 1.77b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.16 > 1.0 |
| NWC/Revenue: -39.74% < 20% (prev 58.25%; Δ -97.99% < -1%) |
| CFO/TA 0.03 > 3% & CFO 2.40b > Net Income 1.77b |
| Net Debt (-6.48b) to EBITDA (2.64b): -2.46 < 3 |
| Current Ratio: 0.84 > 1.5 & < 3 |
| Outstanding Shares: last quarter (11.2m) vs 12m ago -12.50% < -2% |
| Gross Margin: 61.44% > 18% (prev 55.73%; Δ 5.71% > 0.5%) |
| Asset Turnover: 28.26% > 50% (prev 31.61%; Δ -3.35% > 0%) |
| Interest Coverage Ratio: 12.00 > 6 (EBIT TTM 2.46b / Interest Expense TTM 204.7m) |
| A: -0.10 (Total Current Assets 33.6b - Total Current Liabilities 40.2b) / Total Assets 68.6b |
| B: 0.21 (Retained Earnings 14.7b / Total Assets 68.6b) |
| C: 0.04 (EBIT TTM 2.46b / Avg Total Assets 58.6b) |
| D: 0.36 (Book Value of Equity 18.1b / Total Liabilities 50.0b) |
| Altman-Z'' = 0.73 = B |
| DSRI: 3.0 (Receivables 19.0b/4.28b, Revenue 16.6b/15.4b) |
| GMI: 0.91 (GM 55.73% / 61.44%) |
| AQI: 0.62 (AQ_t 0.48 / AQ_t-1 0.77) |
| SGI: 1.08 (Revenue 16.6b / 15.4b) |
| TATA: -0.01 (NI 1.77b - CFO 2.40b) / TA 68.6b) |
| Beneish M = -1.64 (Cap -4..+1) = CCC |
As of July 10, 2026, the stock is trading at USD 1949.44 with a total of 45,785 shares traded. Over the past week, the price has changed by +1.71%, over one month by +7.39%, over three months by -0.37% and over the past year by -2.42%.
Current recommended Stop Loss: 1886.80 (which is 3.2% or 1.6 ATR below the current price).
Markel has received a consensus analysts rating of 3.29. Therefore, it is recommended to hold MKL.
- StrongBuy: 1
- Buy: 0
- Hold: 6
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 1954.5 | 0.3% |
P/E Trailing = 14.315
P/E Forward = 16.8634
P/S = 1.547
P/B = 1.3662
P/EG = 2.5151
Revenue TTM = 16.6b USD
EBIT TTM = 2.46b USD
EBITDA TTM = 2.64b USD
Long Term Debt = 4.38b USD (from longTermDebt, last quarter)
Short Term Debt = 194.8m USD (from shortTermDebt, last fiscal year)
Debt = 4.38b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -6.48b USD (calculated: Debt 4.38b - CCE 10.9b)
Enterprise Value = 18.3b USD (24.8b + Debt 4.38b - CCE 10.9b)
Interest Coverage Ratio = 12.00 (Ebit TTM 2.46b / Interest Expense TTM 204.7m)
EV/FCF = 8.35x (Enterprise Value 18.3b / FCF TTM 2.19b)
FCF Yield = 11.97% (FCF TTM 2.19b / Enterprise Value 18.3b)
FCF Margin = 13.20% (FCF TTM 2.19b / Revenue TTM 16.6b)
Net Margin = 10.70% (Net Income TTM 1.77b / Revenue TTM 16.6b)
Gross Margin = 61.44% ((Revenue TTM 16.6b - Cost of Revenue TTM 6.39b) / Revenue TTM)
Gross Margin QoQ = 67.14% (prev 69.59%)
Tobins Q-Ratio = 0.27 (Enterprise Value 18.3b / Total Assets 68.6b)
Interest Expense / Debt = 4.67% (Interest Expense 204.7m / Debt 4.38b)
Taxrate = 21.10% (486.3m / 2.31b)
NOPAT = 1.94b (EBIT 2.46b * (1 - 21.10%))
Current Ratio = 0.84 (Total Current Assets 33.6b / Total Current Liabilities 40.2b)
Debt / Equity = 0.24 (Debt 4.38b / totalStockholderEquity, last quarter 18.1b)
Debt / EBITDA = -2.46 (Net Debt -6.48b / EBITDA 2.64b)
Debt / FCF = -2.96 (Net Debt -6.48b / FCF TTM 2.19b)
Total Stockholder Equity = 18.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.02% (Net Income 1.77b / Total Assets 68.6b)
RoE = 9.84% (Net Income TTM 1.77b / Total Stockholder Equity 18.0b)
RoCE = 10.96% (EBIT 2.46b / Capital Employed (Equity 18.0b + L.T.Debt 4.38b))
RoIC = 6.98% (NOPAT 1.94b / Invested Capital 27.7b)
WACC = 7.24% (E(24.8b)/V(29.1b) * Re(7.87%) + D(4.38b)/V(29.1b) * Rd(4.67%) * (1-Tc(0.21)))
Discount Rate = 7.87% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.88 | Cagr: -7.19%
[DCF] Terminal Value 75.88% ; FCFF base≈2.16b ; Y1≈2.23b ; Y5≈2.50b
[DCF] Fair Price = 3.60k (EV 38.6b - Net Debt -6.48b = Equity 45.1b / Shares 12.5m; r=8.35% [WACC [floored]]; 5y FCF grow 3.39% → 2.50% )
EPS Correlation: 83.15 | EPS CAGR: 21.82% | SUE: -0.71 | # QB: 0
Revenue Correlation: 43.38 | Revenue CAGR: 1.96% | SUE: -0.24 | # QB: 0
EPS current Quarter (2026-06-30): EPS=29.89 | Chg30d=+3.78% | Revisions=-17% | Analysts=5
EPS next Quarter (2026-09-30): EPS=27.27 | Chg30d=-4.40% | Revisions=-50% | Analysts=4
EPS current Year (2026-12-31): EPS=107.10 | Chg30d=-4.00% | Revisions=-50% | GrowthEPS=-4.5% | GrowthRev=-0.6%
EPS next Year (2027-12-31): EPS=116.49 | Chg30d=-4.31% | Revisions=-50% | GrowthEPS=+8.8% | GrowthRev=+3.1%
[Analyst] Revisions Ratio: -67% (up=1, down=11)